A carregar...
Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
Major breakthroughs have been achieved in the management of metastatic pancreatic ductal adenocarcinoma (PDAC) with FOLFIRINOX (5-fluorouracil + irinotecan + oxaliplatin) and gemcitabine plus nab-paclitaxel approved as a first-line therapy, although the prognosis is still poor. At progression, patie...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264726/ https://ncbi.nlm.nih.gov/pubmed/34285720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211018539 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|